Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Ossur Hf : Q2 2018 Results - Conference call Thursday 26 July at 9:00 CET

Ossur Hf
Posted on: 10 Jul 18

Announcement no. 44/2018
10 July 2018

Conference call on Thursday 26 July at 9:00 CET / 7:00 GMT / 3:00 EDT

Össur will publish its financial results for Q2 2018 prior to market opening on Thursday 26 July. That same day at 9:00 CET, Össur will host a conference call where Jon Sigurdsson, President and CEO, and Sveinn Solvason, CFO, will present and discuss the results of the quarter. The conference call will be conducted in English.

A webcast can be followed on the Össur website: www.ossur.com/investors

To participate in the conference call please call one of the following telephone numbers:

DK: + 45 35 44 55 80
UK: + 44 (0) 203 364 5374
SE: + 46 (0) 8 505 564 74
US: + 1 855 753 2230
IS: + 354 800 7417

Material related to the results will be made available on the following websites:
- The Company's website: http:// www.ossur.com/investors
- Nasdaq's News System:  http://www.nasdaqomxnordic.com/news/
- The Thomson Reuters website:  http://www.thomsonreutersone.com

Further information

David Hreidarsson, Investor Relations, dohreidarsson@ossur.com, +354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide. www.ossur.com .



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ossur Hf via GlobeNewswire
HUG#2204201
GlobeNewswire
globenewswire.com

Last updated on: 11/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.